SCHEMBL18503947

SCHEMBL18503947

c1ccc(-c2cccc(-c3cccc(-c4cccc(-c5cccc(-c6cc(-c7cccc(-c8cccc9ccccc89)c7)c7ccccc7n6)c5)c4)c3)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACA Q13085 4/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
ACHE P22303 1/20 0.46
HPGD P15428 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
LMNA P02545 3/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
DHODH Q02127 1/20 0.44
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
AKR1C1 Q04828 1/20 0.43
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 4/20 0.43
MAPT P10636 4/20 0.43
TDP1 Q9NUW8 3/20 0.43
MAPK1 P28482 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18504008 0.98 ACACA (0.49) ACACAMEN1KMT2AACHEHPGD
SCHEMBL18503955 0.95 ACACA (0.56) ACACAMEN1KMT2AACHEHPGD
SCHEMBL18504007 0.94 ACACA (0.55) ACACAMEN1KMT2AACHEHPGD
SCHEMBL22057462 0.94 ACACA (0.57) ACACAMEN1KMT2AACHEHPGD
SCHEMBL18503975 0.92 ACACA (0.56) ACACAACHEHPGDSMN1; SMN2LMNA
SCHEMBL18504063 0.91 ACACA (0.49) ACACAMEN1KMT2AACHEHPGD
SCHEMBL18504006 0.90 ACACA (0.55) ACACAACHEHPGDSMN1; SMN2LMNA
SCHEMBL18503953 0.89 ACACA (0.60) ACACAMEN1KMT2AACHEHPGD
SCHEMBL13767909 0.89 ACACA (0.60) ACACAMEN1KMT2AACHEHPGD
SCHEMBL18504060 0.88 ACACA (0.52) ACACAMEN1KMT2AACHEHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device OXER1, OCIAD1, OCIAD2 ACACA 1286/4885MEN1 1724/4885KMT2A 4198/4885
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OCIAD2 ACACA 1286/4885MEN1 1724/4885KMT2A 4198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.